Read Article

Supporting international business matching, LSMIP propritizes "Speed" and "Accuracy" in out service.
Please be noted that contents are in English/Japanese, translated on a request basis from authors/members.
国際間のビジネス・マッチングを促進するため、LSMIPでは情報発信の迅速性・正確性を重視しております。
コンテンツは各言語(英語、日本語)でお読みいただけますが、必要に応じて翻訳する場合があります。

Overview

0

[Yakuji Nippo]Collaborative Research with Data Analysis – Three Companies including LDI Assess the Outcome of Cancer Patients

Life Data Initiative (LDI), NTT DATA Corporation, and Pfizer Inc. made an announcement on the December 14th that the three...
  • Target market
    Japan
  • Business category
    Pharmaceutical, Biopharmaceutical, Regerative medicine, Medical device, Digital health, Others
  • Business function
    Marketing >
  • Keyword
  • Author
    "LSMIP Editorial Office" of "CM Plus Corporation"
  • Availability
    Membership

Detail


株式会社薬事日報社から許諾を受けて、株式会社シーエムプラスが英語に翻訳しております。
オリジナルの正式言語は日本語であり、内容および解釈については日本語が優先されます。
With permission from Yakuji Nippo, Limited, CM Plus Corporation translated into English.
The original article is authored in Japanese, and the Japanese shall prevail in meaning in terms of content and interpretation.

 

Collaborative Research with Data Analysis – Three Companies including LDI Assess the Outcome of Cancer Patients
December 16th, 2020

Life Data Initiative (LDI), NTT DATA Corporation, and Pfizer Inc. made an announcement on the December 14th that the three would analyze medical big data including electronic medical record information and advance the research on the methodology to assess clinical outcome of cancer patients. The three entered a contract which aimed to provide anonymously processed medical information based on the Next Generation Medical Infrastructure Act, and they will make beneficial use of research findings for the development of personalized medicine, early development of pharmaceuticals, and so forth.
 

(Continue to the next)


For this translated article in English, CM Plus Corporation shall have the copyright.
Unauthorized reproduction of posted articles, photos, diagrams, etc. is prohibited.
Copyright © 2020 LSMIP office / CM Plus Singapore Pte. Ltd.

Comments (Require approval)

What information are you looking for in articles?
Let us help you to find out the articles for your business requirements!
Like many other companies, we use cookies and other technologies, some of which are essential to make our website work. By clicking Accept or continuing to use our site, you agree to use these cookies and other technologies. To learn more, check out our privacy policy.
Accept